Neal J. Meropol serves as vice president of research oncology at Flatiron Health, where he focuses on real-world evidence generation and academic partnerships. He is nationally recognized for his research contributions in gastrointestinal malignancies and health services research, including evaluation of new agents, predictors of response and outcome, and assessment of the economic impact of care. Neal has also conducted in-depth research on the unique decision-making calculus of cancer patients, and the drivers and barriers to clinical trial participation. Neal recently completed a four-year term as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO), and currently serves as a mentor in the ASCO Leadership Development Program. He is also chair emeritus of the Gastrointestinal Steering Committee of the National Cancer Institute. Prior to joining Flatiron, Neal served as professor and chief of the division of hematology and oncology, at University Hospitals Cleveland Medical Center and Case Western Reserve University, and associate director for clinical research at the Case Comprehensive Cancer Center. In addition to publication of more than 250 manuscripts, he has been recognized by Castle Connolly as a leading physician.